Implementation of a pharmacist-provided pharmacogenomics service in an executive health program von Liko, Ina, Corbin, Lisa, Tobin, Eric, Aquilante, Christina L, Lee, Yee Ming

Volltext

Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent von De, Tanima, Alarcon, Cristina, Hernandez, Wenndy, Liko, Ina, Cavallari, Larisa H, Duarte, Julio D, Perera, Minoli A

Volltext

Providers’ perspectives on the clinical utility of pharmacogenomic testing in pediatric patients von Liko, Ina, Lee, Yee Ming, Stutzman, Danielle L., Blackmer, Allison B., Deininger, Kimberly M., Reynolds, Ann M., Aquilante, Christina L.

Volltext

Clinical effect of von Quinn, Alison LH, Liko, Ina, Lee, James C

Volltext

Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience von Aquilante, Christina L., Kao, David P., Trinkley, Katy E., Lin, Chen-Tan, Crooks, Kristy R., Hearst, Emily C., Hess, Steven J., Kudron, Elizabeth L., Lee, Yee Ming, Liko, Ina, Lowery, Jan, Mathias, Rasika A., Monte, Andrew A., Rafaels, Nicholas, Rioth, Matthew J., Roberts, Emily R., Taylor, Matthew R. G., Williamson, Connie, Barnes, Kathleen C.

Volltext

Clinical effect of CYP2C95/6 genotype on a patient's warfarin dose requirement von Quinn, Alison Lh, Liko, Ina, Lee, James C

Volltext

Abstract 11877: Beta-blocker Dose Stratifies Both Mortality Risk and Circulating Procollagen Levels In African-Americans With Heart Failure von Duarte, Julio D, Arwood, Meghan J, Liko, Ina, Mansour, Ibrahim, Kansal, Mayank, Stamos, Thomas, Cavallari, Larisa H, Desai, Ankit A

Volltext